Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Medicinal Research Reviews|August 14, 2024
Incretin-based therapies for the management of cardiometabolic disease in the clinic: Past, present, and futureJames P Psaltis, Jessica A Marathe, Mau T Nguyen, et al.
BMJ Open Diabetes Research & Care|April 4, 2024
Gastric emptying during and following resolution of moderate diabetic ketoacidosis in type 1 diabetes: a case seriesRyan J Jalleh, Liza Phillips, Mahesh M Umapathysivam, et al.
Physiological Reviews|May 11, 2026
Impact of gastric emptying and small intestinal carbohydrate absorption on glycemia in health and diabetes: therapeutic implicationsRyan J Jalleh, Tongzhi Wu, Mahesh M Umapathysivam, et al.
Endocrinology|November 21, 2024
Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal MotilityRyan J Jalleh, Chinmay S Marathe, Christopher K Rayner, et al.
The Journal of Clinical Endocrinology and Metabolism|October 17, 2024
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and TirzepatideRyan J Jalleh, Mark P Plummer, Chinmay S Marathe, et al.
The Journal of Clinical Endocrinology and Metabolism|August 9, 2019
Longitudinal Changes in Fasting and Glucose-Stimulated GLP-1 and GIP in Healthy Older SubjectsHung Pham, Chinmay S Marathe, Liza K Phillips, et al.
Diabetes Research and Clinical Practice|December 10, 2020
Gastric emptying in health and type 2 diabetes: An evaluation using a 75 g oral glucose drinkCong Xie, Weikun Huang, Xuyi Wang, et al.
Acta Diabetologica|December 19, 2019
The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose toleranceChinmay S Marathe, Hung Pham, Jessica A Marathe, et al.
Diabetes, Obesity & Metabolism|January 10, 2019
Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetesKaren L Jones, Rachael S Rigda, Madeline D M Buttfield, et al.
Diabetes & Vascular Disease Research|December 13, 2016
Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetesSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
Pageof 5